These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34726001)

  • 41. Application of a UPLC-MS/MS method for quantitative analysis of 29 synthetic cannabinoids and their metabolites, such as ADB-BUTINACA and MDMB-4en-PINACA in human hair in real cases.
    Liying Z; Min S; Baohua S; Hang C; Xin W; Hongxiao D; Ping X; Yan S
    Forensic Sci Int; 2022 Feb; 331():111139. PubMed ID: 34922285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases.
    Wagmann L; Stiller RG; Fischmann S; Westphal F; Meyer MR
    Arch Toxicol; 2022 Oct; 96(10):2755-2766. PubMed ID: 35788413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of the Metabolic Profiles of "Indazole-3-Carboxamide" and "Isatin Acyl Hydrazone" (OXIZID) Synthetic Cannabinoids in a Human Liver Microsome Model Using UHPLC-QE Orbitrap MS.
    Xiang J; Wen D; Zhao J; Xiang P; Shi Y; Ma C
    Metabolites; 2023 Apr; 13(4):. PubMed ID: 37110234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework.
    Krotulski AJ; Mohr ALA; Diamond FX; Logan BK
    Drug Test Anal; 2020 Jan; 12(1):136-144. PubMed ID: 31788963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of synthetic cannabinoids in wastewater of major cities in China.
    Fan X; Zhang J; Fu X; Zhou B; Xu Z; Huang H; Han S; Li X
    Sci Total Environ; 2022 Jun; 827():154267. PubMed ID: 35247413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative pharmacokinetic and intracerebral distribution of MDMB-4F-BICA in mice following inhalation ('vapor') and subcutaneous injection.
    Xu Y; Li X; Xu P; Yan F; Wang D
    J Pharm Biomed Anal; 2024 Apr; 241():115988. PubMed ID: 38301574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolism of dipentylone in zebrafish and human liver microsomes determined by liquid chromatography-high resolution mass spectrometry.
    Tang Y; Xu L; Zhao J; Xiang P; Yan H
    J Pharm Biomed Anal; 2023 Nov; 236():115710. PubMed ID: 37690187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New Synthetic Cannabinoid ADB-BUTINACA-Related Death of a Police Dog.
    Tokarczyk B; Suchan M; Adamowicz P
    J Anal Toxicol; 2023 Mar; 47(2):e23-e28. PubMed ID: 36472351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioral pharmacology of five novel synthetic cannabinoids.
    Gatch MB; Tourigny A; Shetty RA; Forster MJ
    Behav Pharmacol; 2022 Apr; 33(2&3):175-183. PubMed ID: 33595956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of AMB-FUBINACA Biotransformation Pathways in Human Liver Microsome and Zebrafish Systems by Liquid Chromatography-High Resolution Mass Spectrometry.
    Xu DQ; Zhang WF; Li J; Wang JF; Qin SY; Lu JH
    Front Chem; 2019; 7():240. PubMed ID: 31041306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous fatal poisoning of two victims with 4F-MDMB-BINACA and ethanol.
    Simon G; Tóth D; Heckmann V; Mayer M; Kuzma M
    Forensic Toxicol; 2023 Jan; 41(1):151-157. PubMed ID: 36652056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver.
    Kavanagh P; Pechnikov A; Nikolaev I; Dowling G; Kolosova M; Grigoryev A
    J Anal Toxicol; 2022 Jul; 46(6):641-650. PubMed ID: 34341821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.
    Gaunitz F; Lehmann S; Thomas A; Thevis M; Rothschild MA; Mercer-Chalmers-Bender K
    Int J Legal Med; 2018 Nov; 132(6):1645-1657. PubMed ID: 30219927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The identification of synthetic cannabinoids in English prisons.
    Abbott MJ; Dunnett J; Wheeler J; Davidson A
    Forensic Sci Int; 2023 Jul; 348():111613. PubMed ID: 36922254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cocaine esterase occurrence in global wastewater microbiomes and potential for biotransformation of novel psychoactive substances.
    de Campos EG; de Almeida OGG; De Martinis BS; De Martinis ECP
    Environ Microbiol Rep; 2022 Feb; 14(1):96-109. PubMed ID: 34761870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of three novel new psychoactive substances 4F-AB-BUTINACA, AB-PHETINACA, and 2F-NENDCK.
    Wang KD; Yuan XL; Liu C; Cao FQ; Zhang YR; Liu WB; He SY
    Drug Test Anal; 2023 Jan; 15(1):115-122. PubMed ID: 35986510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis.
    Axelsson MAB; Lövgren H; Kronstrand R; Green H; Bergström MA
    Basic Clin Pharmacol Toxicol; 2022 Nov; 131(5):420-434. PubMed ID: 36028947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A current overview of the pharmacological composition of "La Chimique" consumed in Mayotte: Preliminary results of the CHASSE-MAREE protocol.
    Richeval C; Gish A; Cottereau V; Peyre A; Pleignet E; Cherki S; Allorge D; Gaulier JM; Devault DA
    Drug Test Anal; 2024 Jun; 16(6):558-569. PubMed ID: 37798946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine.
    Gampfer TM; Wagmann L; Park YM; Cannaert A; Herrmann J; Fischmann S; Westphal F; Müller R; Stove CP; Meyer MR
    Arch Toxicol; 2020 Jun; 94(6):2009-2025. PubMed ID: 32249346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.